Crossmark

Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

Crossref DOI link: https://doi.org/10.1038/s41598-017-09795-w

Published Online: 2017-08-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Garscha, Ulrike

Romp, Erik

Pace, Simona

Rossi, Antonietta

Temml, Veronika

Schuster, Daniela https://orcid.org/0000-0002-9933-8938
König, Stefanie

Gerstmeier, Jana

Liening, Stefanie

Werner, Markus

Atze, Heiner

Wittmann, Sandra

Weinigel, Christina

Rummler, Silke

Scriba, Gerhard K.

Sautebin, Lidia

Werz, Oliver
License Information

Text and Data Mining valid from 2017-08-24

Version of Record valid from 2017-08-24
More Information

Article History

Received: 5 May 2017

Accepted: 31 July 2017

First Online: 24 August 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below